ViiV Healthcare HIV drug Cabenuva outperforms daily oral therapy in teens
Go back to ViiV Healthcare HIV drug Cabenuva outperforms daily oral therapy in teens| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 49.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.89 | 52 Week High | $45.58 | |||
| Open | $49.89 | 52 Week Low | $37.82 | |||
| Day High | $49.89 | P/E | N/A | |||
| Day Low | $49.89 | EPS | $0.00 | |||
| Volume | 77,399 | |||||
